Jake Simson - 10 Jun 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Tighe Reardon, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
10 Jun 2021
Transactions value $
$0
Form type
3
Date filed
10 Jun 2021, 19:20
Next filing
14 Sep 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.